• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETBF2813C145E
Medical Device Problem Code Occlusion Within Device (1423)
Health Effect - Clinical Code Occlusion (1984)
Date of Event 02/06/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Concomitant medical products: etlw1613c124e, sn (b)(4), expiration date: 2018-11-10, udi # (b)(4).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant ii stent graft system was implanted in a patient for the endovascular treatment a 5 cm in diameter abdominal aortic aneurysm.It was reported the patient returned for follow up.The ct revealed that the left endurant iliac limb was occluded up to the flow divider.The physician elected to perform thrombolysis within the stent grafts.The occlusion was corrected and blood flow was restored.The physician cannot determine the cause of the event.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
Film evaluation summary: the exact cause of the left limb occlusion could not be determined from the films provided.Angio¿s at implant were not available for review; the blood flow dynamics could not be assessed from the ct¿s provided.The pre-implant films returned revealed that the patient had a 25mm diameter distal aortic which was extremely calcified; 15 ¿ 20mm flow lumen diameter.Films returned from 5 weeks post-implant revealed that thrombus was observed along the inner wall of the bifurcate aortic body, and the left/contra limb was 100% occluded beginning at the flow divider.Blood flow reconstituted distally at the left iliac bifurcation.The right limb was patent.Within the distal aorta the left/contra limb was observed to be compressed down to 7mm id (10mm od), and at the distal end the 13mm nominal diameter limb narrowed down to ~6mm id (8mm od).It is possible that the iliac limb compression within the calcified distal aorta and distal segment of the lcia which resulted in a diameter restriction, contributed to the occlusion due to the flow restriction.This may also have been caused by a patient condition: poor distal runoff, an unknown coagulopathy that is now presenting, or a previous history of pad.
 
Additional Manufacturer Narrative
Corrected information: sex, date of birth, no eval explain code.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key6392623
Report Number2953200-2017-00354
Device Sequence Number798047
Product Code MIH
UDI-Device Identifier00613994991294
UDI-Public00613994991294
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/13/2018
Device Model NumberETBF2813C145E
Device Catalogue NumberETBF2813C145E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2017
Initial Date Received by Manufacturer 02/13/2017
Supplement Date Received by ManufacturerNot provided
03/30/2017
Initial Report FDA Received Date03/09/2017
Supplement Report FDA Received Date04/19/2017
09/29/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
-
-